HealthStream, Inc.
NASDAQ:HSTMMedical - Healthcare Information Services
-$0.34 today
- Market cap
- $831.60M
- Beta
- 0.47
- P/E (TTM)
- 37.8
- EPS (TTM)
- $0.68
- Dividend yield
- 0.51%
Volume 0.38M
Average 0.25M
HSTM EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
HealthStream, Inc.NASDAQ: HSTM
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA growth accelerates
Q1 FY2026 EBITDA of $19.19M rose 19.9% year over year, ahead of the +7.2% change in trailing-twelve-month EBITDA. Sequentially, it rose 38.1% from the prior quarter. Over 3 fiscal years it compounded at +7.6% a year.
Context
- EBITDA amounted to 21.9% of revenue in FY2025, down 0.7 pp from a year earlier.
- EBITDA increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 4 analysts of $66.85M (+0.2%) for the fiscal year ending Dec 2026, a pace similar to FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $19.19M+38.1% QoQ
- Last fiscal yearDec 2025
- $66.7M+1.0% YoY
- LTMMar 2026
- $69.88M+7.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +19.9% | -1.3% | -21.1 pp |
| 1 year | +1.0% | +0.2% | -0.8 pp |
| 3-year CAGR | +7.6% | -3.4% | -11.0 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 66.7M USD
- Year-over-year change
- +1.0%
- 4-year CAGR
- +10.6%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 66.7M | +1.0% |
| FY2024 | 2024-12-31 | 66.05M | +10.8% |
| FY2023 | 2023-12-31 | 59.59M | +11.3% |
| FY2022 | 2022-12-31 | 53.53M | +20.1% |
| FY2021 | 2021-12-31 | 44.58M | — |
EBITDA vs competitors
How HSTM compares with its peers on the latest reported figures
- HSTM's LTM Mar 2026 EBITDA of $69.88M is the highest of the 10 companies compared; the peer median is $11.6M.
- Its year-over-year change of +7.2% is the 6th highest of 10, against a peer median of +17.2%.
- EBITDA amounts to 22.4% of revenue for HSTM, versus a peer median of 16.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $69.88M | +7.2% | +7.6% | 22.4% | |
| LTM Jun 2026 | $68.17M | +79.4% | — | 2.9% | |
| LTM Apr 2026 | $42.42M | +563.3% | — | 8.6% | |
| LTM Mar 2026 | $28.3M | +17.2% | +10.4% | 22.8% | |
| LTM Mar 2026 | $27.87M | -32.4% | -15.0% | 20.1% | |
| LTM Mar 2026 | $11.6M | +101.6% | — | 4.9% | |
| LTM Mar 2026 | -$4.22M | -227.5% | — | 1.9% | |
| LTM Mar 2026 | -$53.01M | +56.9% | — | 22.3% | |
| LTM Mar 2026 | -$192.37M | -1267.9% | — | 63.6% | |
| LTM Mar 2026 | -$314.51M | -1056.6% | — | 16.7% | |
| Peer median (excluding HSTM) | $11.6M | +17.2% | -2.3% | 16.7% | |
Competitors are the stored peer set for HSTM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 256.71M | 266.83M | 279.06M | 291.65M | 304.06M |
| Cost of Revenue | 91.03M | 91.14M | 95.02M | 97.94M | 107.21M |
| Gross Profit | 165.68M | 175.68M | 184.04M | 193.71M | 196.86M |
| Gross Margin | 64.5% | 65.8% | 65.9% | 66.4% | 64.7% |
| Research & Development | 41.66M | 44.28M | 45.54M | 48.89M | 50.98M |
| Selling, General & Admin | 79.15M | 81.01M | 81.41M | 82.29M | 82.16M |
| Operating Expenses | 157.62M | 163.23M | 168.02M | 172.42M | 176.62M |
| Depreciation & Amortization | 36.81M | 37.95M | 41.08M | 41.24M | 43.48M |
| EBITDA | 44.58M | 53.53M | 59.59M | 66.05M | 66.7M |
| EBITDA Margin | 17.4% | 20.1% | 21.4% | 22.6% | 21.9% |
| Operating Income | 8.06M | 12.45M | 16.02M | 21.29M | 20.24M |
| Operating Margin | 3.1% | 4.7% | 5.7% | 7.3% | 6.7% |
| Interest Income | 0 | 444K | 2.36M | 3.83M | 3.34M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (289K) | 3.14M | 2.49M | 3.52M | 2.98M |
| Income Before Tax | 7.77M | 15.59M | 18.51M | 24.8M | 23.22M |
| Pre-Tax Margin | 3.0% | 5.8% | 6.6% | 8.5% | 7.6% |
| Income Tax Expense | 1.92M | 3.49M | 3.3M | 4.8M | 4.88M |
| Net Income | 5.85M | 12.09M | 15.21M | 20.01M | 18.34M |
| Net Margin | 2.3% | 4.5% | 5.5% | 6.9% | 6.0% |
| EPS (Basic) | 0.19 | 0.39 | 0.50 | 0.66 | 0.61 |
| EPS (Diluted) | 0.18 | 0.39 | 0.50 | 0.66 | 0.61 |
| Weighted Avg Shares | 31.53M | 30.65M | 30.57M | 30.39M | 30.02M |
| Weighted Avg Shares (Diluted) | 31.62M | 30.72M | 30.67M | 30.54M | 30.14M |
HealthStream, Inc.
NASDAQ:HSTM
Intrinsic Alpha fair value
Locked
Current Price
$27.18
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.